Casodex

Casodex is a brand name of bicalutamide, approved by the FDA in the following formulation(s):

CASODEX (bicalutamide - tablet; oral)

• 
  Manufacturer: ASTRAZENECA
  
  Approval date: October 4, 1995
  
  Strength(s): 50MG ^[RLD][AB]

Has a generic version of Casodex been approved?

A generic version of Casodex has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Casodex and have been approved by the FDA:

bicalutamide tablet; oral

• 
  Manufacturer: ACCORD HLTHCARE INC
  
  Approval date: July 6, 2009
  
  Strength(s): 50MG ^[AB]


• 
  Manufacturer: ACTAVIS TOTOWA
  
  Approval date: August 28, 2009
  
  Strength(s): 50MG ^[AB]


• 
  Manufacturer: FRESENIUS KABI ONCOL
  
  Approval date: May 13, 2010
  
  Strength(s): 50MG ^[AB]


• 
  Manufacturer: KUDCO IRELAND
  
  Approval date: July 6, 2009
  
  Strength(s): 50MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: July 6, 2009
  
  Strength(s): 50MG ^[AB]


• 
  Manufacturer: ROXANE
  
  Approval date: March 24, 2011
  
  Strength(s): 50MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: July 6, 2009
  
  Strength(s): 50MG ^[AB]


• 
  Manufacturer: SUN PHARMA GLOBAL
  
  Approval date: July 6, 2009
  
  Strength(s): 50MG ^[AB]


• 
  Manufacturer: SYNTHON PHARMS
  
  Approval date: July 6, 2009
  
  Strength(s): 50MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: July 6, 2009
  
  Strength(s): 50MG ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA INC
  
  Approval date: July 6, 2009
  
  Strength(s): 50MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Casodex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Casodex.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • December 19, 2011 - ADDITIONAL INFO FOR PEDIATRIC USE FOR CASODEX (STUDIED IN COMBINATION WITH ARIMIDEX) IN THE PEDIATRIC POPULATION, SPECIFICALLY BOYS WITH FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY (TESTOXICOSIS)
  
  
  • June 19, 2012 - PEDIATRIC EXCLUSIVITY
  
  

See also...

• Casodex Consumer Information (Drugs.com)
• Casodex Consumer Information (Wolters Kluwer)
• Casodex Consumer Information (Cerner Multum)
• Casodex Advanced Consumer Information (Micromedex)
• Casodex AHFS DI Monographs (ASHP)
• Bicalutamide Consumer Information (Wolters Kluwer)
• Bicalutamide Consumer Information (Cerner Multum)
• Bicalutamide Advanced Consumer Information (Micromedex)
• Bicalutamide AHFS DI Monographs (ASHP)